✦ LIBER ✦

A phase II study of a potent and selective aromatase inhibitor, anastrozole (ZD-1033), in Japanese postmenopausal women with advanced/recurrent breast cancer

✍ Scribed by H. Koyama

Book ID: 117666202
Publisher: Elsevier Science
Year: 1998
Tongue: English
Weight: 147 KB
Volume: 34
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(98)80081-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical Dosage Determination of a New A

Clinical Dosage Determination of a New Aromatase Inhibitor, Anastrozole, in Postmenopausal Japanese Women with Advanced Breast Cancer

✍ Yasuo Nomura, Hiroki Koyama, Yasuo Ohashi, Hiroshi Watanabe 📂 Article 📅 2000 🏛 Springer International Publishing AG 🌐 English ⚖ 249 KB

104. Randomized phase III study of the n

104. Randomized phase III study of the new selective aromatase inhibitor arimidex (A) (ZD1033) versus megestrol acetate (MA) in the treatment of postmenopausal women with advanced breast cancer

✍ A.U. Buzdar; P.V. Plourde; S.E. Jones; C.L. Voge; J.M. Wolters; P.D. Eisenberg 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 188 KB

A Phase III trial comparing anastrozole

A Phase III trial comparing anastrozole (1 and 10 milligrams), a potent and selective aromatase inhibitor, with megestrol acetate in postmenopausal women with advanced breast carcinoma

✍ Aman U. Buzdar; Stephen E. Jones; Charles L. Vogel; Janet Wolter; Paul Plourde; 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB 👁 2 views

The trial was randomized, double blind for anastrozole, open label for for the Arimidex Study Group megestrol acetate, parallel group, and multicenter. Patients were randomly assigned to receive anastrozole, 1 mg (n Å 128); anastrozole, 10 mg (n Å 130); or

Activity of megestrol acetate in postmen

Activity of megestrol acetate in postmenopausal women with advanced breast cancer after nonsteroidal aromatase inhibitor failure: a phase II trial

✍ Bines, J.; Dienstmann, R.; Obadia, R. M.; Branco, L. G. P.; Quintella, D. C.; Ca 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 170 KB

373 Phase II trial of letrozole (a novel

373 Phase II trial of letrozole (a novel oral nonsteroidal aromatase inhibitor) in postmenopausal patients with advanced or recurrent breast cancer

✍ T. Tominaga; Y. Ohashi; R. Abe; M. Yoshida; H. Koyama; Y. Nomura; A.S. Bhatnagar 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 153 KB

A study of the effects of the aromatase

A study of the effects of the aromatase inhibitors anastrozole and letrozole on bone metabolism in postmenopausal women with estrogen receptor-positive breast cancer

✍ Fiona M. McCaig; Lorna Renshaw; Linda Williams; Oliver Young; Juliette Murray; E 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 286 KB